| 201 |
10170450 | Cost effectiveness in the treatment of heart failure with ramipril. A Swedish substudy of the AIRE study. Acute Infarction Ramipril Efficacy. | 1997 Aug |
1 |
| 202 |
8771657 | [The efficacy of treatment with the angiotensin-converting enzyme inhibitor ramipril in patients with congestive heart failure of rheumatic etiology]. | 1996 |
1 |
| 203 |
8834929 | Mega-trials: is meta-analysis an alternative? | 1996 |
1 |
| 204 |
8902551 | Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system. | 1996 |
1 |
| 205 |
8908384 | Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation. | 1996 Nov |
1 |
| 206 |
9081852 | The DIAB-HYCAR Study. | 1996 Dec |
1 |
| 207 |
7585774 | Angiotensin-converting enzyme inhibitors post-myocardial infarction. | 1995 Aug |
1 |
| 208 |
7607751 | Long term effects of ACE inhibitors on the erythrocytosis in renal transplant recipients. | 1995 Jan |
1 |
| 209 |
7768254 | Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramipril. | 1995 |
2 |
| 210 |
7774515 | Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure. | 1995 Mar |
3 |
| 211 |
7786840 | Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials. | 1995 Feb |
1 |
| 212 |
7787145 | The study of the effect of intensity of blood pressure management on the progression of type 1 diabetic nephropathy: study design and baseline patient characteristics. Collaborative Study Group. | 1995 Apr |
1 |
| 213 |
8617412 | Role of the renin-angiotensin system in systemic and regional vascular responses to orthostatic stress in healthy volunteers. | 1995 |
2 |
| 214 |
8682064 | Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use. | 1995 Dec |
1 |
| 215 |
8984131 | ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study on behalf of the RACE study group. | 1995 Nov |
2 |
| 216 |
11850671 | Efficacy and Safety of Ramipril in Hypertensive Single-Kidney Patients. | 1995 May |
1 |
| 217 |
7857733 | Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure. | 1994 Dec |
1 |
| 218 |
7868871 | Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension? | 1994 Nov |
2 |
| 219 |
8042078 | The Grande Roche ACE debate. | 1994 Feb |
1 |
| 220 |
8137599 | Clinical pharmacokinetics of ramipril. | 1994 Jan |
1 |
| 221 |
8205743 | Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure. | 1994 Mar |
1 |
| 222 |
7681510 | Angiotensin converting enzyme inhibition does not prevent the natriuretic effect of felodipine. | 1993 Mar |
2 |
| 223 |
8117516 | [Rational criteria for the choice of ACE inhibitor adapted to the individual hypertensive patient]. | 1993 Oct |
1 |
| 224 |
8276048 | Acute haemodynamic effects and pharmacokinetics of ramipril in patients with heart failure. A placebo controlled three-dose study. | 1993 |
2 |
| 225 |
8299664 | The acute haemodynamic and renal effects of oral felodipine and ramipril in healthy subjects. | 1993 |
1 |
| 226 |
8321736 | Comparison of ramipril and enalapril in patients with essential hypertension. | 1993 May-Jun |
5 |
| 227 |
1282625 | Effect of bradykinin on arteries and veins in systemic and pulmonary circulation. | 1992 |
1 |
| 228 |
1329465 | Drug-patient interactions and their relevance in the treatment of heart failure. | 1992 Oct 8 |
2 |
| 229 |
1411408 | [Monotherapy with the ACE-inhibitor ramipril or the calcium antagonist nitrendipine in essential hypertension]. | 1992 Oct 3 |
1 |
| 230 |
1532570 | Ramipril: a review of the new ACE inhibitor. | 1992 Feb |
3 |
| 231 |
1535400 | Is natriuresis on felodipine due to reversal of the renal effects of angiotensin II? | 1992 May |
2 |
| 232 |
1646621 | A study of the acute pharmacodynamic interaction of ramipril and felodipine in normotensive subjects. | 1991 Feb |
1 |
| 233 |
1650862 | [Effects of the angiotensin converting enzyme inhibitor ramipril on calcium (Ca2+) kinetics in smooth muscle cells]. | 1991 |
2 |
| 234 |
1661764 | Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man. | 1991 Nov |
5 |
| 235 |
1725019 | Effect of angiotensin-converting enzyme inhibition on human tissue renin. | 1991 |
4 |
| 236 |
1725027 | Comparison of response rates to the angiotensin-converting enzyme inhibitor ramipril in mild-to-moderate hypertension in a double-blind, parallel-group study and an open single-blind study. | 1991 |
2 |
| 237 |
1725028 | Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial. | 1991 |
1 |
| 238 |
1725030 | Effects of ramipril on arterial hemodynamics. | 1991 |
2 |
| 239 |
1834452 | More ACE inhibitors--quinapril, perindopril & ramipril. | 1991 Apr 15 |
1 |
| 240 |
1837563 | Long lasting arterial effects of the ACE inhibitor ramipril. | 1991 Oct |
3 |
| 241 |
2138076 | Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders. | 1990 Jan |
4 |
| 242 |
2138704 | [Acute effects of the angiotensin converting enzyme inhibitor ramipril in patients with coronary heart disease]. | 1990 Feb 15 |
4 |
| 243 |
2141472 | Metabolic effects of ramipril treatment in hypertensive subjects with non-insulin-dependent diabetes mellitus. | 1990 Apr |
1 |
| 244 |
2143594 | [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril]. | 1990 Jun 21 |
1 |
| 245 |
2147879 | Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications. | 1990 |
3 |
| 246 |
2226219 | Angiotensin converting enzyme inhibitors and moderate hypertension. | 1990 Sep |
1 |
| 247 |
2257720 | Angiotensin-converting enzyme inhibition in patients with essential hypertension. | 1990 |
1 |
| 248 |
2474101 | Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function. | 1989 |
4 |
| 249 |
2474102 | Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV). | 1989 |
4 |
| 250 |
2474105 | Therapeutic efficacy and tolerance of ramipril in hypertensive patients with renal failure. | 1989 |
1 |